The short answer
Mild cognitive impairment, or MCI, means a noticeable change in thinking or memory while a person remains largely independent. It does not always progress to dementia. Finding the cause matters, because treatment and follow-up depend on what is driving the change.
MCI vs. normal aging vs. dementia
- Normal aging: occasional word-finding lapses or slower recall that don't disrupt function.
- MCI: a noticeable, measurable decline (often in memory) that others or testing can detect, but you're still independent in daily activities.
- Dementia: cognitive decline significant enough to interfere with independent daily living.
The line between MCI and dementia is functional: can you still manage your day independently? MCI says yes, with effort; dementia says not without help. This three-way distinction traces back to the criteria first laid out by the researcher who defined MCI as a distinct clinical category, specifically to capture people who had measurable memory impairment beyond normal aging but who were not yet demented, a framework that clinicians still use today (Petersen, 1999, Arch Neurol; DOI).
Why MCI doesn't always mean dementia
MCI does not always progress to dementia. Some people remain stable, some improve, and others develop dementia. A 2017 meta-analysis found that progression varied substantially across studies and between clinic and community populations. Its pooled percentage is not a five-year forecast for an individual.
Evaluation matters because sleep disorders, medication effects, thyroid problems, depression, and vitamin B12 deficiency can contribute to cognitive symptoms. Menopause-related brain fog also deserves attention, but should not automatically be labeled MCI.
The women angle
Menopause symptoms and clinically measurable cognitive impairment are different questions that can overlap in how they feel. A symptom pattern or life stage cannot diagnose the cause. Evaluation is useful precisely because it looks beyond that first assumption.
Is MCI treatable?
Treatment depends on the cause. A clinician may address medication effects, sleep disorders, B12 deficiency, thyroid problems, or mood. Cardiovascular care and appropriate activity also matter.
Some people with MCI due to Alzheimer’s disease may be eligible for approved treatments. For example, FDA-approved donanemab is intended to begin at the MCI or mild-dementia stage of Alzheimer’s. Eligibility requires a specific assessment, and treatment has meaningful risks. This is different from a medicine that reverses MCI of every cause. FDA treatment information.
Lithium research in MCI remains a separate, investigational question. A supplement should not replace evaluation or established treatment.
When to see a clinician
If you or those around you notice a real, persistent change in memory or thinking, see a clinician for assessment. The goal is to understand the cause, identify treatment options, address contributing factors (thyroid, B12, sleep, mood, medications) and to monitor over time. Earlier evaluation gives you more options.
Frequently asked questions
What is mild cognitive impairment (MCI)?
Measurable decline in memory or thinking that's greater than normal aging but not severe enough to disrupt independent daily life. That functional line, first defined in the clinical criteria for MCI, is what separates it from dementia (Petersen, 1999).
Does MCI always turn into dementia?
No. A meta-analysis found roughly a third of people with amnestic MCI progressed to dementia within five years, meaning most did not (Hu et al., 2017). Many remain stable for years and some return to normal, especially when a treatable cause is found and addressed.
What's the difference between MCI and dementia?
It's about daily function. With MCI you're still independent; with dementia cognitive decline interferes with managing daily life without help.
Can MCI be reversed?
Some contributors to thinking difficulties are treatable, and some people improve. MCI has different causes. If Alzheimer’s is the cause, approved therapies may be an option for selected patients; they are not a general reversal treatment. FDA information.
Is menopause brain fog the same as MCI?
Not usually. Menopause fog is typically temporary and tied to the transition, while MCI is a measurable, persistent decline. Telling them apart is a good reason to get evaluated.
Related reading
- Menopause brain fog: why it happens
- Cognitive reserve: building a brain that ages well
- Lithium and dementia: what the evidence says
References
- Gildengers, Ibrahim, Anderson et al. (2026). Low-Dose Lithium for Mild Cognitive Impairment. JAMA Neurology.
- Hu, Yu, Sun et al. (2017). The prevalence and progression of mild cognitive impairment among clinic and community populations: a systematic review and meta-analysis. International Psychogeriatrics.
- Petersen, Smith, Waring et al. (1999). Mild Cognitive Impairment. Archives of Neurology.
